In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 3621-81-6, name is 2,5-Dichlorobenzooxazole, introducing its new discovery. SDS of cas: 3621-81-6
Pd/PTABS: Low Temperature Etherification of Chloroheteroarenes
A mild, general, and highly efficient catalytic etherification protocol for chloroheteroarenes was developed using the Pd/PTABS catalytic system. The protocol is selective for the etherification of chloroheteroarenes using a large variety of electron-rich and electron-deficient phenol bearing synthons which include inter alia biologically and commercially important estrone, estradiol, tyrosine, and several other molecules. The mildness of the new protocol is expected to be beneficial for the synthesis of complex drugs and drug intermediates offering late-stage modification of bioactive compounds.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 3621-81-6, and how the biochemistry of the body works.SDS of cas: 3621-81-6
Reference£º
Benzoxazole – Wikipedia,
Benzoxazole | C7H5NO – PubChem